Liposomal formulation of amphotericin B approved for marketing.
D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D017277:Drug Approval; D004337:Drug Carriers; D006801:Humans; D008081:Liposomes; D014481:United States; D014486:United States Food and Drug Administration
D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B